Table 2.

Comparison of the levels of fasting glucose and insulin, HOMA-IR, and FGF21 in chronic hepatitis C patients vs controls

Variables	Patients (n=75)	Controls (n=40)	P-values
Fasting glucose (mmol/dL), mean±SD	5.04±0.75	4.7±0.52	0.01
Fasting insulin level (uIU/mL), mean±SD	20.15±5.13	13.15±4.2	0.001
HOMA-IR, mean±SD	4.49±1.28	2.72±0.87	0.001
FGF21 (ng/mL), mean±SD	123.7±52.6	21.8±8.8	0.001

Abbreviations: FGF21, fibroblast growth factor 21; HOMA-IR, homeostasis model of insulin resistance.